← Leaderboards
Linda M Nicholas
University Of North Carolina Chapel Hill
$1,559,955
Attributed
$1,559,955
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,559,955 · 3
By mechanism
M01$1,559,955 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Robert N Golden$31,944,665
- Douglas A Drossman$8,090,089
- Cort A Pedersen$7,997,634
- Jeffrey A Lieberman$17,412,506
- Melanie S Joy$4,717,709
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectTriglyceridesCholesterolBlood /Lymphatic PharmacologyBlood LipidDrug /AgentMental Disorder ChemotherapyHuman Therapy EvaluationPlacebosSocial PsychologyDrug MetabolismAnticonvulsantsBupropionClinical DepressionDrug Administration Rate /DurationAdult Human (21+)Drug Screening /EvaluationOutcomes ResearchPhobias
Grant awards (13)
EFFECTS OF MIRTAZAPINE ON PLASMA LIPIDS IN HEALTHY SUBJECTS$190,747
M01 · FY2002 · RR
EFFECTS OF MIRTAZAPINE ON PLASMA LIPIDS IN HEALTHY SUBJECTS$294,555
M01 · FY2001 · RR
EFFECTS OF MIRTAZAPINE ON PLASMA LIPIDS IN HEALTHY SUBJECTS$190,747
M01 · FY2001 · RR
EFFECTS OF MIRTAZAPINE ON PLASMA LIPIDS IN HEALTHY SUBJECTS$294,555
M01 · FY2000 · RR
EFFECTS OF MIRTAZAPINE ON PLASMA LIPIDS IN HEALTHY SUBJECTS$294,555
M01 · FY2000 · RR
EFFECTS OF MIRTAZAPINE ON PLASMA LIPIDS IN HEALTHY SUBJECTS$294,555
M01 · FY2000 · RR
EFFECTS OF MIRTAZAPINE ON PLASMA LIPIDS IN HEALTHY SUBJECTS$241
M01 · FY2000 · RR
EFFICACY OF PREGABALIN IN PATIENTS WITH SOCIAL PHOBIA$0
M01 · FY2000 · RR
EFFICACY OF PREGABALIN IN PATIENTS WITH SOCIAL PHOBIA$0
M01 · FY2000 · RR
BUPROPION SR IN ATYPICAL DEPRESSION$0
M01 · FY2000 · RR
BUPROPION SR IN ATYPICAL DEPRESSION$0
M01 · FY2000 · RR
BUPROPION SR IN ATYPICAL DEPRESSION$0
M01 · FY2000 · RR
EFFICACY OF PREGABALIN IN PATIENTS WITH SOCIAL PHOBIA$0
M01 · FY2000 · RR